公开(公告)号：EP3154609A1

公开(公告)日：2017-04-19

申请号：EP15809382.3

申请日：2015-06-16

申请人： Hospira, Inc.

发明人： DAY, WIlliam ,  RUCHTI, Timothy

IPC分类号： A61M5/172

CPC分类号： A61M5/1723 ,  A61M5/365 ,  A61M2005/14208 ,  A61M2005/16863 ,  A61M2205/16 ,  A61M2205/18 ,  A61M2205/3553 ,  G06F19/00 ,  G16H20/10 ,  G16H20/17

摘要： A system and method for monitoring and delivering medication to a patient. The system includes a controller that has a control algorithm and a closed loop control that monitors the control algorithm. A sensor is in communication with the controller and monitors a medical condition. A rule based application in the controller receives data from the sensor and the closed loop control and compares the data to predetermined medical information to determine the risk of automation of therapy to the patient. A system monitor is also in communication with the controller to monitor system, remote system, and network activity and conditions. The controller then provides a predetermined risk threshold where below the predetermined risk threshold automated closed loop medication therapy is provided. If the predetermined risk threshold is met or exceeded, automated therapy adjustments may not occur and user/clinician intervention is requested.

摘要翻译： 一种用于监视和提供药物给病人的系统和方法。 该系统包括一个控制器做具有控制算法和闭环控制监视器所做的控制算法。 传感器与所述控制器进行通信并监测医学状况。 在控制器的一个基于规则的应用从所述传感器和所述闭环控制接收数据并将数据与预定的医疗信息疗法的自动化的风险进行比较，以确定矿给患者。 因此，一个系统监视器是与控制器以监视系统，远程系统和网络活动和条件的通信。 然后，控制器提供的下方设置所述预定风险阈值自动闭环药物治疗，其中的预定风险阈值。 如果预定的风险阈值达到或超过，自动调整治疗可能不会发生，并要求用户/临床医生的干预。